You are here:
- Funding Opportunities
- Funding Process
- Funded Research
- Clinical Research
- Policies & Guidelines
Updated December 15, 2014
Review of Grant Applications
Frequently Asked Questions About Review
Whom to contact
In general, you do not need to contact NIAMS after submitting your application. If we need any further information or material, NIAMS will contact you.
However, if you must contact NIAMS, the appropriate personnel to contact are:
(a) BEFORE REVIEW of your application — the Scientific Review Officer (SRO) identified in your eRA Commons account; and
(b) AFTER REVIEW — the Program Officer (or Program Director) identified on the front of your summary statement and in your eRA Commons account.
Whom to contact before review
From the time your application has been submitted until the time of the review meeting, all correspondence about your application should be directed to the Scientific Review Officer (SRO) identified in your eRA Commons account.
Whom to contact after review
After the review meeting, all correspondence about your application should be directed to the Program Officer identified on the front of your summary statement and in your eRA Commons account.
How to identify a study section where your grant should be reviewed (self referral)
What happens to your research project grant (R01/R03/R21) application after it is received for peer review
Will an application be reviewed by a CSR Study Section or a NIAMS Study Section
The Center for Scientific Review (CSR) manages the initial review groups that review most of the investigator-initiated applications. NIAMS manages the review of applications submitted in response to special solicitations and for unique programs, including applications responding to requests for applications (RFAs) or requests for proposals (RFPs), applications responding to some program announcements with set-aside funds, applications for cooperative agreements and research center grants, and certain investigator-initiated applications (e.g., training grants, career development awards, and clinical trials applications).